ENTX Entera Bio Ltd.
Healthcare$1.21-2.42%ClosedMarket Cap: $59.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
5.54
P/S
0.00
EV/EBITDA
-4.62
DCF Value
$0.14
FCF Yield
-15.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-88.0%
ROA
-94.3%
ROIC
-106.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-3.5M | $-3.5M | $— | — |
| Q4 null | $0.00 | NaN% | $-3.0M | $-3.0M | $— | — |
| FY null | $42.0K | 0.0% | $-11.5M | $-11.4M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-3.3M | $-3.2M | $— | — |
| Q2 null | $0.00 | NaN% | $-2.7M | $-2.7M | $— | — |
| Q1 null | $42.0K | 0.0% | $-2.6M | $-2.6M | $— | — |
| Q4 null | $82.0K | 0.0% | $-2.3M | $-2.4M | $— | — |
| FY null | $181.0K | 5.0% | $-9.6M | $-9.5M | $— | — |
| Q3 null | $42.0K | 0.0% | $-3.0M | $-3.0M | $— | — |
| Q2 null | $57.0K | 15.8% | $-2.2M | $-2.1M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-2.1M | $-2.0M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-2.0M | $-2.0M | $-0.07 | — |